Involvement of a cyclic-AMP pathway in group I metabotropic glutamate receptor responses in neonatal rat cortex

By Schaffhauser H.   de Barry J.   Muller H.   Heitz M.-P.   Gombos G.   Mutel V.  

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 289-297

Elsevier

Access to resources Recommend Favorite

Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice

By Spooren W.P.J.M.   Gasparini F.   van der Putten H.   Koller M.   Nakanishi S.   Kuhn R.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Tetranactin inhibits interleukin 1 and cAMP induction of group II phospholipase A 2 in rat renal mesangial cells

By Walker G.   Kunz D.   Pignat W.   Wiesenberg I.   Van den Bosch H.   Pfeilschifter J.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 574-595

Bentham Science Publishers

Access to resources Recommend Favorite

Different effects of NMDA/group I metabotropic glutamate receptor agents in - and -opioid receptor agonist-induced supraspinal antinociception

By Suzuki T.   Aoki T.   Ohnishi O.   Nagase H.   Narita M.  

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite